Outcome of patients with IDH1/2-mutated post myeloproliferative neoplasm AML in the era of IDH inhibitors

被引：45

作者：

Chifotides, Helen T. ^{[1
]}

Masarova, Lucia ^{[1
]}

Alfayez, Mansour ^{[1
]}

Daver, Naval ^{[1
]}

Alvarado, Yesid ^{[1
]}

Jabbour, Elias ^{[1
]}

Konopleva, Marina ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Patel, Keyur P. ^{[2
]}

DiNardo, Courtney D. ^{[1
]}

Verstovsek, Srdan ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

来源：

BLOOD ADVANCES | 2020年 / 4卷 / 21期

基金：

美国国家卫生研究院;

关键词：

LEUKEMIC TRANSFORMATION; CELL TRANSPLANTATION; MUTATIONS; MYELOFIBROSIS; RUXOLITINIB; PROGNOSIS;

D O I：

10.1182/bloodadvances.2020001528

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5336 / 5342

页数：7

共 41 条

[1] Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation [J].

Alchalby, Haefaa ;

Zabelina, Tatjana ;

Stuebig, Thomas ;

van Biezen, Anja ;

Bornhaeuser, Martin ;

Di Bartolomeo, Paolo ;

Beelen, Dietrich ;

Cahn, Jean Yves ;

Dreger, Peter ;

Schroyens, William ;

de Witte, Theo ;

Olavarria, Eduardo ;

Kroeger, Nicolaus .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :279-281

[2] A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia [J].

Bose, Prithviraj ;

Verstovsek, Srdan ;

Cortes, Jorge E. ;

Tse, Susan ;

Gasior, Yvonne ;

Jain, Nitin ;

Jabbour, Elias J. ;

Estrov, Zeev ;

Alvarado, Yesid ;

DiNardo, Courtney D. ;

Pemmaraju, Naveen ;

Kornblau, Steven M. ;

Kadia, Tapan M. ;

Daver, Naval G. ;

Naqvi, Kiran ;

Short, Nicholas J. ;

Masarova, Lucia ;

Villareal, John ;

Pierce, Sherry A. ;

Nogueras-Gonzalez, Graciela ;

Huang, Xuelin ;

Garcia-Manero, Guillermo ;

Kantarjian, Hagop M. ;

Ravandi, Farhad .

LEUKEMIA, 2020, 34 (09) :2489-2492

[3] Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia [J].

Chan, Steven M. ;

Thomas, Daniel ;

Corces-Zimmerman, M. Ryan ;

Xavy, Seethu ;

Rastogi, Suchita ;

Hong, Wan-Jen ;

Zhao, Feifei ;

Medeiros, Bruno C. ;

Tyvoll, David A. ;

Majeti, Ravindra .

NATURE MEDICINE, 2015, 21 (02) :178-184

[4]

Chihara DKH, 2016, BLOOD, V128

[5] Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML [J].

Choe, Sung ;

Wang, Hongfang ;

DiNardo, Courtney D. ;

Stein, Eytan M. ;

de Botton, Stephane ;

Roboz, Gail J. ;

Altman, Jessica K. ;

Mims, Alice S. ;

Watts, Justin M. ;

Pollyea, Daniel A. ;

Fathi, Amir T. ;

Tallman, Martin S. ;

Kantarjian, Hagop M. ;

Stone, Richard M. ;

Quek, Lynn ;

Konteatis, Zenon ;

Dang, Lenny ;

Nicolay, Brandon ;

Nejad, Parham ;

Liu, Guowen ;

Zhang, Vickie ;

Liu, Hua ;

Goldwasser, Meredith ;

Liu, Wei ;

Marks, Kevin ;

Bowden, Chris ;

Biller, Scott A. ;

Attar, Eyal C. ;

Wu, Bin .

BLOOD ADVANCES, 2020, 4 (09) :1894-1905

[6] Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML [J].

DiNardo, C. D. ;

Stein, E. M. ;

de Botton, S. ;

Roboz, G. J. ;

Altman, J. K. ;

Mims, A. S. ;

Swords, R. ;

Collins, R. H. ;

Mannis, G. N. ;

Pollyea, D. A. ;

Donnellan, W. ;

Fathi, A. T. ;

Pigneux, A. ;

Erba, H. P. ;

Prince, G. T. ;

Stein, A. S. ;

Uy, G. L. ;

Foran, J. M. ;

Traer, E. ;

Stuart, R. K. ;

Arellano, M. L. ;

Slack, J. L. ;

Sekeres, M. A. ;

Willekens, C. ;

Choe, S. ;

Wang, H. ;

Zhang, V. ;

Yen, K. E. ;

Kapsalis, S. M. ;

Yang, H. ;

Dai, D. ;

Fan, B. ;

Goldwasser, M. ;

Liu, H. ;

Agresta, S. ;

Wu, B. ;

Attar, E. C. ;

Tallman, M. S. ;

Stone, R. M. ;

Kantarjian, H. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25) :2386-2398

[7]

DINARDO CD, 2019, J CLIN ONCOL S, V37

[8] How I treat acute myeloid leukemia in the era of new drugs [J].

DiNardo, Courtney D. ;

Wei, Andrew H. .

BLOOD, 2020, 135 (02) :85-96

[9] SOHO State of the Art Update and Next Questions: IDH Therapeutic Targeting in AML [J].

DiNardo, Courtney D. ;

Stein, Eytan M. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (12) :769-772

[10]

Dinardo CD, 2020, J CLIN ONCOL, V38

← 1 2 3 4 5 →